<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04634201</url>
  </required_header>
  <id_info>
    <org_study_id>2019_14</org_study_id>
    <secondary_id>2020-A02179-30</secondary_id>
    <nct_id>NCT04634201</nct_id>
  </id_info>
  <brief_title>Effect of Probiotics on the Periodontal Status of Orthodontic Patients</brief_title>
  <acronym>POP</acronym>
  <official_title>Effect of Probiotics in Addition to Dental Brushing on Gum Inflammation and Oral Microbiota in Patients With Fixed Orthodontic Appliances</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sunstar, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gingival inflammation (gingivitis) is commonly reported in teenagers with fixed orthodontic&#xD;
      devices (FOD). Indeed, FODs promote the accumulation of plaque and interfere with the&#xD;
      efficacy of tooth brushing. According to in vitro and in vivo studies, the administration of&#xD;
      oral probiotic bacteria including Lactobacillus reuteri may reduce the number of periodontal&#xD;
      pathogens in saliva and dental plaque. A recent systematic review shows a positive effect of&#xD;
      probiotics in addition to tooth brushing in the treatment of periodontitis. However, there is&#xD;
      insufficient data regarding the effect of probiotics in the prevention of gum diseases. The&#xD;
      aim of this double-blind randomized placebo-controlled study is to assess the effect of&#xD;
      probiotics, in addition to dental brushing, on gum inflammation and the composition of the&#xD;
      oral microbiota in teenagers with fixed orthodontic appliances&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Variation of gingival index (Löe Silness) between baseline and 6 months</measure>
    <time_frame>At 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>bleeding on probing (BOP) score (% of BOP sites)</measure>
    <time_frame>At Baseline, at 3 months and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plaque index (O'leary)</measure>
    <time_frame>At Baseline, at 3 months and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dysbiosis index</measure>
    <time_frame>At Baseline, at 3 months and 6 months</time_frame>
    <description>Shannon-weaver, alpha rarefaction, beta diversity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of salivary markers of inflammation -</measure>
    <time_frame>At Baseline, at 3 months and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>compliance level record</measure>
    <time_frame>At Baseline, at 3 months and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Periodontal Health</condition>
  <condition>Gingivitis</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral probiotics (L. reuteri)</intervention_name>
    <description>administration of probiotic containing tablets twice daily after tooth brushing for 3 months</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>administration of a placebo twice daily after tooth brushing for 3 months</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adolescents aged 12 to 16 benefiting from social security coverage&#xD;
&#xD;
          -  in good general health in brushing and taking treatments&#xD;
&#xD;
          -  Have FODs&#xD;
&#xD;
          -  who consent to the study and whose parents have given their consent&#xD;
&#xD;
          -  suitable for orthodontic treatment in view of his oral state&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  inability to obtain informed consent&#xD;
&#xD;
          -  use of another probiotic or toothpaste / antiseptic mouthwash ≤ 1 month before&#xD;
             inclusion&#xD;
&#xD;
          -  allergy or hypersensibiliity to the active substance or to any of the excipients&#xD;
             listed in the Gum® PerioBalance® user guide)&#xD;
&#xD;
          -  no history of antibiotic therapy, antiseptic mouthwash ≤ 1 month before inclusion&#xD;
&#xD;
          -  medical contraindication (immunosuppression, pathology requiring prophylactic&#xD;
             antibiotic therapy before dental care)&#xD;
&#xD;
          -  physiological, pathological condition, medication or behavior that may have&#xD;
             repercussions on the oral cavity (eg: pregnancy, diabetes, antiepileptics, tobacco)&#xD;
&#xD;
          -  oral state requiring other priority care (untreated cavities, untreated active&#xD;
             periodontitis, progressive recession)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevimy AGOSSA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kevimy AGOSSA, MD</last_name>
    <phone>0320445962</phone>
    <email>kevimy.agossa@univ-lille.fr</email>
  </overall_contact>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 16, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gingivitis</keyword>
  <keyword>oral microbiota</keyword>
  <keyword>salivary biomarkers</keyword>
  <keyword>probiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

